Jie Hao

Title: **Inventor Jie Hao: Pioneering Anti-Cerebral Ischemia Solutions**

Introduction

Jie Hao is an accomplished inventor based in Suzhou, China, renowned for his contributions to the field of pharmaceuticals. With two patents to his name, he has made significant strides in developing innovative compounds aimed at combating cerebral ischemia, a condition that can lead to severe neurological complications. His work focuses on harnessing natural materials to create effective medical solutions.

Latest Patents

Jie Hao's latest patents include:

1. **Oxidized β-1,4-oligoglucuronic acid, and preparation method therefor and uses thereof** - This invention employs abundant cellulose as a raw material, oxidizing all six-site hydroxyl groups of cellulose β-1,4-polyglucose into carboxyl groups to produce glucuronic acid. The process utilizes a sodium bromide (NaBr)-2,2,6,6-tetramethyl piperidine oxide (TEMPO)-sodium hypochlorite (NaClO) oxidation system. The resulting oxidized oligoglucuronic acid displays significant anti-cerebral ischemia activity, indicating its potential as a therapeutic drug for this condition.

2. **Oxidized α-1,4-oligoglucuronic acid, and preparation method therefor and uses thereof** - Similar to his previous patent, this innovation uses soluble starch as the raw material, facilitating the oxidation of all six-site hydroxyl groups in starch α-1,4-polyglucose to form glucuronic acid. The compound, also produced under the same oxidation conditions, shows promising anti-cerebral ischemia activity, underscoring its potential as a new pharmaceutical agent.

Career Highlights

Jie Hao is currently affiliated with Shanghai Green Valley Pharmaceutical Co., Ltd., where his research and innovations contribute significantly to the company’s commitment to developing advanced therapeutic solutions. His expertise in utilizing natural resources for drug development sets him apart in the competitive pharmaceutical landscape.

Collaborations

Throughout his career, Jie Hao has collaborated with talented peers, including Zhenqing Zhang and Shichang Sun. These collaborative efforts have enabled him to enhance his research capabilities and drive impactful innovations forward.

Conclusion

Inventor Jie Hao represents a vital force in the pharmaceutical industry with his inventive methodologies aimed at treating cerebral ischemia. His groundbreaking work, exemplified by his latest patents, showcases the potential of using natural materials in medical innovations. As he continues to develop novel solutions at Shanghai Green Valley Pharmaceutical Co., Ltd., the impact of his work on healthcare could be profound.